STAT Plus: Pharmalittle: Drug costs rose 10.5% this 12 months; Senate committee probes teams tied to opioid makers

Rise and shine, everybody, one other busy day is on the best way. Regardless of the quick week on this facet of the pond, the world retains spinning, which implies there may be a lot to do. So time to fireside up the espresso kettle and down one other cup of stimulation — our alternative in the present day is sweet cane, consider it or not — and, as all the time, we invite you to hitch us. In the meantime, listed below are a number of objects of curiosity that can assist you in your journey. Hope all goes effectively and also you conquer the world. …

Prescription drug costs jumped 10.5% over the previous six months, not as quick the 15% seen throughout the identical interval final 12 months however nonetheless 4 instances sooner than inflation, regardless of growing strain from the Trump administration and Congress on the pharmaceutical business, in line with information from RxSavings Options. The typical improve on July 1, a time when drug makers typically raises value, was 13.1%, in contrast with 7.eight% a 12 months in the past. And costs rose on 104 medicines this week, versus 318 in 2018.

Unlock this text by subscribing to STAT Plus and revel in your first 30 days free!


What’s it?

STAT Plus is a premium subscription that delivers every day market-moving biopharma protection and in-depth science reporting from a staff with many years of business expertise.

What’s included?

Authoritative biopharma protection and evaluation, interviews with business pioneers, coverage evaluation, and first appears to be like at innovative laboratories and early stage analysis
Subscriber-only networking occasions and panel discussions throughout the nation
Month-to-month subscriber-only reside chats with our reporters and consultants within the area
Discounted tickets to business occasions and early-bird entry to business reviews